Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Apiam Animal Health Ltd. ( (AU:AHX) ) just unveiled an update.
Apiam Animal Health has disclosed a change in the form of director Vita Pepe’s indirect interest in the company’s shares, with 13,074,123 fully paid ordinary shares being moved off-market from a superannuation fund to the Vita Pepe Family Trust. The transaction does not alter the total number of shares held under Pepe’s indirect control, implying no change to the director’s overall economic exposure to Apiam, and was confirmed as not involving trading during a closed period, signalling a routine internal restructuring of holdings rather than a change in strategic positioning.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Limited is an Australian veterinary and animal health company that operates across the livestock and companion animal sectors, providing veterinary services and related animal health products to rural and regional markets.
Average Trading Volume: 467,503
Technical Sentiment Signal: Buy
Current Market Cap: A$161M
Find detailed analytics on AHX stock on TipRanks’ Stock Analysis page.